RP-HPLC with Time Programmed Fluorescence Detection for Quantitation of Avanafil and Dapoxetine Hydrochloride: Application to Pharmaceutical Dosage Form and Biological Fluid

References

• Limin, M.; Johnson, N.; Hellstrom, W. J.; Avanafil, A New Rapid-Onset Phosphodiestrase 5 Inhibitor for the Treatment of Erectile Dysfunction. Exp. Opin. Invest. Drugs. 2010, 19, 1427–1437.
   PubMed Web of Science ®Google Scholar
• Goldstein, I.; McCullough, A.; Jones, L.; et al. A Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction. J. Sexual Med. 2012, 9, 1122–1133.
   PubMed Web of Science ®Google Scholar
• Zhao, C.; Kim, S.; Yan, D.; et al. Efficacy and Safety of Avanafil for Treating Erectile Dysfunction: Results of a Multicentre, Randomized, Double-blind, Placebo-controlled Trial. BJUI Int. 2012, 110, 1801–1806.
   PubMed Web of Science ®Google Scholar
• Goldstein, I.; Jones, L. A.; Belkoff, L. H.; Karlin, G. S.; Bowden, C. H.; Peterson, C. A.; Trask, B. A.; Day, W. W. Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-blind Study in Men with Diabetes Mellitus. Mayo Clin. Proc. 2012, 9, 843–852.
   Web of Science ®Google Scholar
• Belkoff, L. H.; McCullough, A.; Goldstein, I.; Jones, L.; Bowden, C. H.; DiDonato, K.; Trash, B.; Day, W. W. An open-Label, Long-Term Evaluation of the Safety, Efficacy and Tolerability of Avanafil in Male Patients with Mild to Severe Erectile Dysfunction. Int. J. Clin. Pract. 2013, 4, 333–341.
   Web of Science ®Google Scholar
• Gengo, P. J.; Giuliano, F.; McKenna, K.; et al. Monoaminergic Transporter Binding and Inhibition Profile of Dapoxetine, A Medication for the Treatment of Premature Ejaculation, J. Urol. 2005, 173, 239–244.
   PubMed Web of Science ®Google Scholar
• Kendirci, M.; Salem, E.; Hellstrom, W. J. Dapoxetine;, A Novel Selective Serotonin Transport Inhibitor for the Treatment of Premature Ejaculation. Ther. Clin. Risk Manage. 2007, 2, 277–289.
   Google Scholar
• Hiemke, C.; Harter, S. Pharmacokinetics of Selective Serotonin Reuptake Inhibitors. Pharmacol. Ther. 2000, 85, 11–28.
   PubMed Web of Science ®Google Scholar
• Modi, N. B.; Dresser, M. J.; Simon, M.; Lin, D.; Desai, Gupta, S. Single- and Multiple-dose Pharmacokinetics of Dapoxetine Hydrochloride, A Novel Agent for the Treatment of Premature Ejaculation. J. Clin. Pharmacol. 2006, 46, 301–309.
   PubMed Web of Science ®Google Scholar
• Pryor, J. L.; Althof, S. E.; Steidle, C.; Rosen, R. C.; Hellstrom, W. J.; Shabsigh, R.; Miloslavsky, M.; Kell, S. Efficacy and Tolerability of Dapoxetine in Treatment of Premature Ejaculation: An Integrated Analysis of Two Double-Blind, Randomized Controlled Trials. Lancet. 2006, 368, 929–937.
   PubMed Web of Science ®Google Scholar
• Buvat, J.; Tesfaye, F.; Rothman, M.; Rivas, D. A.; Giuliano, F.; Dapoxetine for the Treatment of Premature Ejaculation: Results From A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries. Eur. Urol. 2009, 55, 957–968.
   PubMed Web of Science ®Google Scholar
• Dresser, M. J.; Desai, D.; GidwanI, S.; Seftel, A. D.; Modi, N. B.; Dapoxetine, A Novel Treatment for Premature Ejaculation, Doesn’t Have Pharmacokinetic Interactions with Phosphodiesterase -5 Inhibitors. Int. J. Impotence Res. 2006, 18, 104–110.
   PubMed Web of Science ®Google Scholar
• Mangukiya, M.; Rathod, B.; Dhaduk, D.; Maniya, J. Development and Validation of a Reversed Phase HPLC Method for Simultaneous Determination of Avanafil and Dapoxetine Hydrochloride in Combined Pharmaceutical Formulation. Pharm. Anal. Qual. Assur. 2013, 2013.
   Google Scholar
• Kashyap, R.; Srinivasa, U. Badodaria, K. Development and Validation of RP-HPLC Method for Simultaneous Estimation Avanafil and Dapoxetine Hydrochloride in Bulk and Dosage Form. World J. Pharm. Pharm. Sci., 2014, 3, 1697–1719.
   Google Scholar
• Mangukiya, M. A.; Patel, G. F.; Rathod, B. G.; Dhaduk, D. M.; Maniya, J. B. Development and Validation of Spectroscopic Methods for Simultaneous Estimation of Avanafil and Dapoxetine Hydrochloride in Combined Dosage Form. Pharm. Anal. Qual. Assur. 2013, 2013.
   Google Scholar
• Kashyap, R.; Srinivasa, U.; Badodaria, K. First Order Derivative and Dual Wavelength Spectrophotometry Methods Development and Validation For Simultaneous Determination of Avanafil and Dapoxetine Hydrochloride in Bulk and Dosage Form. Int. J. Pharm. Technol. 2014, 6, 6418–6438.
   Google Scholar
• Chaudhari, H. H.; Sen, D. J.; Patel, C. N. Development and Validation of HPTLC Method for Simultaneous Estimation of Avanafil and Dapoxetine HCl in Tablet Dosage Form. World J. Pharm. Pharm. Sci. 2015, 4, 1566–1575.
   Google Scholar
• Hamilton, C. L.; Cornpropst, J. D. Determination of Dapoxetine, an Investigational Agent with the Potential for Treating Depression, and its Mono- and di-desmethyl Metabolites in Human Plasma using Column-Switching High-Performance Liquid Chromatography. J. Chromatogr. B. 1993, 612, 253–261.
   Web of Science ®Google Scholar
• International Conference of Harmonization of technical requirements for registration of pharmaceuticals for human use (ICH). http://www.nihs.go.jp
   Google Scholar